Clinical Trials
3 trialsNCT05155332 2026-05-20
A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)
Boehringer Ingelheim
Phase 1 Suspended
NCT06728657 2025-06-18
TORCH-G
Fudan University
Phase 2 Suspended
NCT03779100 2019-01-28
Lenvatinib Plus PD-1 Antibody for Unresectable ICC
Sun Yat-sen University
Phase 2 Suspended